Update on Intravitreal Injectable Drugs and Dry AMD Treatments
Experts InSight
00:00
Introduction
The host and colleagues discuss recent developments in injectable drugs for retinal diseases, including dry AMD, wet AMD, and diabetic macular edema. They focus on the FDA's surprise denial of approval for Regeneron's ILEA 8mg dose, examining its potential benefits and referencing CNBC's coverage of the FDA's complete response letter.
Transcript
Play full episode
